StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ORIS

Oriental Rise Holdings Limited

ORISF OTC Agricultural Production-Crops EDGAR ↗
$0.21
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$893K
Revenue (TTM) ⓘ
$12.2M
Net income (TTM) ⓘ
$681K
EPS (TTM) ⓘ
$0.34
P/E ratio ⓘ
0.6
Dividend yield ⓘ
—
Free cash flow ⓘ
-$2.98M
Cash ⓘ
$48.4M
Total assets ⓘ
$81.1M
Gross margin ⓘ
10.8%
52-week range ⓘ
$0.21 – $18.56

AI briefing

from the latest 10-K, 10-Q and 8-K events

Oriental Rise Holdings Limited is a Cayman Islands holding company that, through its PRC subsidiaries, operates a tea cultivation and processing business in Fujian Province, China, and is listed on Nasdaq under the symbol ORIS.

What they do

Oriental Rise Holdings Limited, through its PRC operating subsidiaries Fujian Min Dong Hong Tea Technology Co., Ltd. and Fujian Qingjing Agricultural Comprehensive Development Co., Ltd., is engaged in the cultivation, processing, and sale of tea products in the People's Republic of China. The company is headquartered in Zherong County, Ningde City, Fujian Province. Its ordinary shares are registered with the SEC and trade on the Nasdaq Stock Market under the symbol ORIS.

Revenue drivers

  • Tea product sales — The company generates revenue primarily from the sale of tea products cultivated and processed by its PRC operating subsidiaries. This is the sole revenue source disclosed in the filing excerpts; no further segmentation is provided.

Recent performance

For the fiscal year ended December 31, 2025, Oriental Rise reported revenue of $12.2 million, down from $15.0 million in 2024. Net income fell to $681,000 in 2025 from $2.1 million in 2024. Diluted earnings per share were $0.34 in 2025, compared to $3.36 in 2024. Operating cash flow turned negative at $(583,000) in 2025, versus $3.1 million in 2024. As of December 31, 2025, the company had total assets of $81.1 million, total liabilities of $2.8 million, and shareholder equity of $78.4 million, including cash and equivalents of $48.4 million.

Strategy

The filing excerpts do not describe specific strategic initiatives, investments, or priorities beyond the company's general tea operations. No forward-looking guidance or capital allocation plans are provided in the available text. The company's focus remains on its tea cultivation and processing business through its PRC subsidiaries. It is a holding company with no material operations of its own.

Risks

  • Revenue concentration — Revenue has declined from $24.3 million in 2022 to $12.2 million in 2025, indicating a significant contraction in the core tea business.
  • Profitability deterioration — Net income fell from $11.9 million in 2022 to $681,000 in 2025, and operating cash flow turned negative in 2025, raising concerns about sustainable earnings.
  • Geographic and regulatory concentration — All operations are conducted through PRC subsidiaries in Fujian Province, China, subjecting the company to PRC laws, regulations, and economic conditions.
  • Foreign private issuer status — As a Cayman Islands holding company with PRC operating subsidiaries, the company may face additional risks related to corporate structure, taxation, and regulatory compliance.

Outlook

The filing excerpts do not provide management's outlook, guidance, or forward-looking statements beyond cautionary language. No specific plans or projections for future periods are disclosed in the available text.

Recent SEC filings

40 most recent
Annual, quarterly & current reports
Other filings